Group 1 - Northern Long Dragon is planning to acquire the controlling stake of Henan Zhongsheng and raise matching funds, leading to a stock suspension [1] - The company specializes in the research, design, production, and sales of non-metal composite materials for military vehicle equipment [1] - Koyuan Pharmaceutical's major shareholder plans to reduce their stake by up to 3%, amounting to 324.87 million shares [2] Group 2 - Jiaste Technology's shareholder intends to reduce their stake by up to 3%, totaling 1,428.75 million shares [2] - Chengdi Xiangjiang's subsidiary has won a bid for a data center project with China Mobile, valued at 492 million yuan [3] - Zhongchao Holdings' actual controller sold 223 million shares during a period of stock price fluctuation, representing 0.16% of total shares [4] Group 3 - ST Yushun's stock will resume trading after confirming no significant changes in its operational environment [6] - Xing Shuai Er's shareholder plans to reduce their stake by up to 0.37%, equating to 130 million shares [7] - Weiguang Co. intends to reduce its stake by up to 1.32%, totaling 300 million shares [8] Group 4 - Zhongsheng Pharmaceutical's subsidiary has received ethical approval for two Phase III clinical trials for its innovative peptide drug RAY1225 [9][10] - Nongxin Technology's major shareholder plans to reduce their stake by up to 1.35%, amounting to 135 million shares [12] - Mintai Aluminum has signed a strategic cooperation agreement with Penghui Energy for collaboration in battery technology [14] Group 5 - Youyan Powder's controlling shareholder plans to reduce their stake by up to 1%, totaling 103 million shares [16] - Runjian Co. has been shortlisted for a procurement project with China Mobile, valued at 374 million yuan [17] - Bangyan Technology has terminated its plan to issue shares and raise funds for asset acquisition [18] Group 6 - Xianggang Technology's controlling shareholder intends to reduce their stake by up to 3%, equating to 648.42 million shares [19] - Zhongke Shuguang is undergoing a stock suspension due to a planned share swap merger with Haiguang Information [20]

Market Overview - The three major A-share indices collectively adjusted in the morning session, with the Shanghai Composite Index down 0.30%, the Shenzhen Component Index down 0.71%, and the ChiNext Index down 1.28% [1] - The total market turnover for the half-day was 661 billion, a decrease of 1 billion compared to the previous day, with 2,600 stocks in the market showing losses [1] Sector Performance - The controllable nuclear fusion, gaming, and beverage manufacturing sectors led the gains, while the innovative drug sector experienced the largest declines [2] - Notable stocks in the controllable nuclear fusion sector included Haohan Huadong (301137), Xue Ren Co., Ltd. (002639), and Rongfa Nuclear Power (002366), all hitting the daily limit [2] - Gaming stocks also performed well, with Youzu Network (002174) reaching the daily limit [2] - Beverage manufacturing stocks rebounded, with Junyao Health (605388) and Kuaijishan (601579) hitting the daily limit [2] - The autonomous driving sector showed strength, with Jinjiang Online (600650), Tongda Electric (603390), and Longzhou Co., Ltd. (002682) all reaching the daily limit [2] - The innovative drug sector saw significant declines, with Haichen Pharmaceutical (300584) dropping over 10%, and Hainan Hai Pharmaceutical (000566) and San Sheng Guojian also experiencing notable losses [2] Hotspot Overview - The nuclear power sector was highlighted as the strongest market focus, with 11 stocks hitting the daily limit and 5 stocks achieving consecutive limit-ups, including Shangwei Co., Ltd. and Zhongchao Holdings (002471) [7] - The military industry sector also saw 11 stocks hitting the daily limit, with 5 stocks achieving consecutive limit-ups [8] - The artificial intelligence sector had 9 stocks hitting the daily limit, with one stock achieving consecutive limit-ups [9] Key Developments - The controllable nuclear fusion sector is gaining attention following U.S. President Trump's recent executive orders aimed at launching the construction of 10 large nuclear power plants by 2030 and quadrupling the nuclear power capacity by 2050 [10] - The IP economy is also gaining traction, with stocks like Youzu Network and others seeing significant interest, particularly following the recent rise in the market value of Pop Mart in Hong Kong [11] - The autonomous driving sector is attracting capital, with recent funding rounds for companies like Jiushi Intelligent and New Stone Technology, indicating strong investor interest in this area [12]

Core Insights - The pharmaceutical sector experienced a significant net outflow of over 1.578 billion yuan, indicating a negative trend in investor sentiment towards this industry [1][2] - In contrast, sectors such as cultural media, transportation, and precious metals saw net inflows, with cultural media leading at 0.557 billion yuan [1][2] Sector Summary - **Net Inflows**: - Cultural Media: 0.557 billion yuan, 3.93% net inflow rate [2] - Transportation: 0.398 billion yuan, 3.41% net inflow rate [2] - Precious Metals: 0.263 billion yuan, 4.34% net inflow rate [2] - Environmental Protection: 0.237 billion yuan, 4.23% net inflow rate [2] - Power Grid Equipment: 0.232 billion yuan, 1.38% net inflow rate [2] - **Net Outflows**: - Pharmaceuticals: -1.578 billion yuan, -3.26% net outflow rate [2] - Transportation Equipment: -1.219 billion yuan, -2.58% net outflow rate [2] - Complete Automobiles: -0.826 billion yuan, -4.66% net outflow rate [2] - Machinery Equipment: -0.825 billion yuan, -1.54% net outflow rate [2] - Chemical Pharmaceuticals: -0.806 billion yuan, -3.80% net outflow rate [2] Stock Performance - **Top Net Inflows**: - Wuhan Fangu: 0.462 billion yuan, 40.88% net inflow rate [3] - Baobian Electric: 0.322 billion yuan, 26.83% net inflow rate [3] - Shanghai Electric: 0.297 billion yuan, 9.03% net inflow rate [3] - Kaimete Gas: 0.295 billion yuan, 30.69% net inflow rate [3] - Zhongke Information: 0.224 billion yuan, 22.30% net inflow rate [3] - **Top Net Outflows**: - Seris: -0.375 billion yuan, -9.49% net outflow rate [4] - Ningde Times: -0.352 billion yuan, -7.57% net outflow rate [4] - Zhongchao Holdings: -0.296 billion yuan, -11.46% net outflow rate [4] - Huibo Yuntong: -0.281 billion yuan, -10.28% net outflow rate [4] - BYD: -0.247 billion yuan, -4.02% net outflow rate [4]

中超控股（002471）5月25日发布公告，于2025年5月22日、5月23日连续2个交易日收盘价格涨幅偏离值 累计达到22.91%，根据深圳证券交易所的有关规定，属于股票异常波动的情况。经核实，近期公司经 营情况及内外部经营环境未发生重大变化；公司、控股股东和实际控制人不存在应披露而未披露的重大 事项，或处于筹划阶段的重大事项；公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格 产生较大影响的未公开重大信息；实际控制人杨飞卖出其从二级市场增持的股票2,230,000股，占公司总 股本0.16%。公司2025年5月8日披露《关于实际控制人向控股孙公司提供资金支持暨关联交易的公告》 (公告编号：2025-037)，实际控制人杨飞本次减持所得资金将主要用于江苏精铸设备采购等。未来根据 市场情况，杨飞仍会考虑适时增持股票。控股股东在本公司股票交易异常波动期间未买卖本公司股票。 ...

本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动情况 江苏中超控股股份有限公司（以下简称"公司"或"本公司"）于 2025 年 5 月 22 日、5 月 23 日连续 2 个交易日收盘价格涨幅偏离值累计达到 22.91%，根 据深圳证券交易所的有关规定，属于股票异常波动的情况。 二、公司关注、核实情况说明 针对公司股价异常波动，公司就相关事项进行了必要核实，现将有关核实情 况说明如下： 1、经核查，公司前期披露的信息不存在需要更正、补充之处； 2、经核查，公司未发现近期公共媒体报道了可能或已经对本公司股票交易 价格产生较大影响的未公开重大信息； 证券代码：002471 证券简称：中超控股 公告编号：2025-043 江苏中超控股股份有限公司 股票交易异常波动公告 5、经核查，控股股东在本公司股票交易异常波动期间未买卖本公司股票。 本次股票异常波动期间，实际控制人杨飞先生卖出其从二级市场增持的股票 2,230,000 股，占公司总股本 0.16%。公司 2025 年 5 月 8 日披露《关于实际控制 人向控股孙公司提供资金支持暨关联交易的公告 ...

5月23日午间涨停分析 智通财经5月23日电，今日午盘全市场共33股涨停，连板股总数6只，17股封板未遂，封板率为66%（不含ST股、退市股）。焦点股方面，机器人叠加核电概 念的中超控股15天9板，牛磺酸龙头永安药业8天6板，并购重组的滨海能源晋级5连板。 | 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 海森药业 | 2天2板 | 10.01% | 09:25 | 原料药 | | 001367 | | | | | | 众生药业 | 首板 | 10.02% | 09:25 | 创新药 | | 002317 | | | | 上市 | | 多瑞医药 | 首板 | 20.00% | 09:38 | 感冒药 | | 301075 | | | | | | 誉衡药业 | 首板 | 9.84% | 10:02 | 医药 | | 002437 | | | | | | 新天地 | | 18.13% | | 感冒药 | | 301277 | | | | +CRO | | 森萱医药 | | 15.07% | | 感冒药 | | 830946 | ...

中超控股5月22日交易公开信息 | 买/ 卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 国泰海通证券股份有限公司三亚迎宾路证券营业部 | 11044.11 | 1.28 | | 买二 | 国泰海通证券股份有限公司宜昌沿江大道证券营业部 | 5184.41 | 6.33 | | 买三 | 开源证券股份有限公司西安太华路证券营业部 | 4320.15 | 0.00 | | 买四 | 华宝证券股份有限公司上海东大名路证券营业部 | 3321.21 | 45.09 | | 买五 | 华宝证券股份有限公司深圳福华一路证券营业部 | 1767.67 | 4.75 | | 卖一 | 中信证券股份有限公司宜兴新城路证券营业部 | 0.00 | 1766.14 | | 卖二 | 中银国际证券股份有限公司广东分公司 | 0.00 | 1712.39 | | 卖三 | 机构专用 | 812.34 | 913.26 | | 卖四 | 东方财富证券股份有限公司拉萨团结路第一证券营业 部 | 134.55 | 874.68 | | 卖五 | 东方 ...

近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.05.21 | -5.58 | 20.09 | -6522.15 | | 2025.05.20 | -5.29 | 35.13 | -16682.03 | | 2025.05.19 | 10.13 | 41.64 | 2148.83 | | 2025.05.16 | 10.03 | 12.57 | 34229.86 | | 2025.05.15 | -8.88 | 23.96 | -8104.57 | | 2025.05.14 | -6.19 | 31.05 | -14415.00 | | 2025.05.13 | 1.20 | 40.40 | -38790.98 | | 2025.05.12 | 10.08 | 17.73 | 38450.75 | | 2025.05.09 | -4.80 | 42.63 | -53970.61 | | 2025.05.08 | 10.00 | 15.89 | -1276.10 | 注：本文系新闻报道，不构成投资建 ...

证券代码：002471 证券简称：中超控股 公告编号：2025-042 江苏中超控股股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动情况 江苏中超控股股份有限公司（以下简称"公司"或"本公司"）于 2025 年 据深圳证券交易所的有关规定，属于股票异常波动的情况。 二、公司关注、核实情况说明 针对公司股价异常波动，公司就相关事项进行了必要核实，现将有关核实情 况说明如下： 价格产生较大影响的未公开重大信息； 项，或处于筹划阶段的重大事项； 卖本公司股票。 三、是否存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有根据深圳证券交易所《股票上市规则》 等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、协 议等；董事会也未获悉本公司有根据深圳证券交易所《股票上市规则》等有关规 定应予以披露而未披露的、对本公司股票及其衍生品种交易价格产生较大影响的 信息；公司前期披露的信息不存在需要更正、补充之处。 四、必要的风险提示 披露《2025 年一季度报告》，具体内容详见公司刊登于《证券时报》 《证券日报》 和巨 ...

江苏中超控股股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动情况 江苏中超控股股份有限公司（以下简称"公司"或"本公司"）于 2025 年 5 月 16 日、5 月 19 日连续 2 个交易日收盘价格涨幅偏离值累计达到 20.66%，根 据深圳证券交易所的有关规定，属于股票异常波动的情况。 二、公司关注、核实情况说明 针对公司股价异常波动，公司就相关事项进行了必要核实，现将有关核实情 况说明如下： 1、经核查，公司前期披露的信息不存在需要更正、补充之处； 2、经核查，公司未发现近期公共媒体报道了可能或已经对本公司股票交易 价格产生较大影响的未公开重大信息； 3、经核查，近期公司经营情况及内外部经营环境未发生重大变化； 证券代码：002471 证券简称：中超控股 公告编号：2025-042 5、经核查，控股股东、实际控制人在本次公司股票交易异常波动期间未买 卖本公司股票。 三、是否存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有根据深圳证券交易所《股票上市规则》 等有关规定应予以披露而未披露的 ...